You need to enable JavaScript to run this app.
Tatva Chintan Pharma Chem Ltd’s Rs 500-crore initial public offering (IPO) continued to witness huge interest from the investors on the third day of bidding. The issue was subscribed 15.04 times on July 19, the second day IPO subscription.